Heba K. Alshaeri

Design, Synthesis, and Biological Evaluation of New Potential Unusual Modified Anticancer Immunomodulators for Possible Non-Teratogenic Quinazoline-Based Thalidomide Analogs

Reda R. Mabrouk, Abdallah E. Abdallah, Hazem A. Mahdy et al. · International Journal of Molecular Sciences · 2023 · 21 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Medical students’ attitudes toward sleeping pill usage: A cross-sectional study

Moudi M. Alasmari, Raghad S. Alkanani, Asmaa S. Alshareef et al. · Frontiers in Psychiatry · 2022 · 20 citations · Full text

Medicine, Pharmacology, Behavioral Medicine +8

<p>Effects of <em>Annona muricata</em> Extract on Triple-Negative Breast Cancer Cells Mediated Through EGFR Signaling</p>

Heba K. Alshaeri, Moudi M. Alasmari, Zuhair S. Natto et al. · Cancer Management and Research · 2020 · 19 citations · Full text

Medicine, Oncology, Pharmacology +13

Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023

Kayleigh Bhangdia, Miranda L May, Jonathan M Kocarnik et al. · The Lancet Oncology · 2026 · 18 citations · Full text

Medicine, Oncology, Population Health Sciences +17

Design, Synthesis, Molecular Modeling and Anti-Hyperglycemic Evaluation of Quinazoline-Sulfonylurea Hybrids as Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) and Sulfonylurea Receptor (SUR) Agonists

Mohamed Ayman El‐Zahabi, Faida H. Bamanie, Salah Ghareeb et al. · International Journal of Molecular Sciences · 2022 · 17 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13